# Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component

> **NCT00680732** · PHASE4 · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 1370 (actual)

## Conditions studied

- Malaria
- Malaria in Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** Multiple micronutrients supplements (MMS)
- **DIETARY_SUPPLEMENT:** Iron and folic acid (IFA)
- **DRUG:** Chloroquine (CQ)
- **DRUG:** Sulphadoxyne-pyrimethamine (SP)

## Key facts

- **NCT ID:** NCT00680732
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 1370 (ACTUAL)
- **Last updated:** 2010-09-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00680732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00680732, "Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00680732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*